Fervenza, F C <br/><br/>
Rituximab treatment of idiopathic membranous nephropathy.  [electronic resource] 

 -  Kidney international  Jan 2008 
 - 117-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1038/sj.ki.5002628  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived<br/>B-Lymphocytes--immunology<br/>Female<br/>Glomerulonephritis, Membranous--drug therapy<br/>Humans<br/>Immunoglobulins--blood<br/>Immunologic Factors--adverse effects<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Proteinuria--diagnosis<br/>Rituximab<br/>Treatment Outcome